| Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots MS Muthu, SA Kulkarni, A Raju, SS Feng Biomaterials 33 (12), 3494-3501, 2012 | 269 | 2012 |
| Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation Y Li, QL Zhou, W Sun, P Chandrasekharan, HS Cheng, Z Ying, ... Nature cell biology 17 (10), 1327-1338, 2015 | 184 | 2015 |
| Agrin as a mechanotransduction signal regulating YAP through the Hippo pathway S Chakraborty, K Njah, AV Pobbati, YB Lim, A Raju, M Lakshmanan, ... Cell reports 18 (10), 2464-2479, 2017 | 174 | 2017 |
| Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression E Khattar, P Kumar, CY Liu, SC Akıncılar, A Raju, M Lakshmanan, ... The Journal of clinical investigation 126 (10), 4045-4060, 2016 | 120 | 2016 |
| H3K27me3-rich genomic regions can function as silencers to repress gene expression via chromatin interactions Y Cai, Y Zhang, YP Loh, JQ Tng, MC Lim, Z Cao, A Raju, ... Nature communications 12 (1), 719, 2021 | 110 | 2021 |
| Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel A Raju, MS Muthu, SS Feng Expert Opinion on Drug Delivery 10 (6), 747-760, 2013 | 76 | 2013 |
| Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers R Kumar, L Coronel, B Somalanka, A Raju, OA Aning, O An, YS Ho, ... Nature communications 9 (1), 3931, 2018 | 61 | 2018 |
| GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers SAK Rasheed, HS Leong, M Lakshmanan, A Raju, D Dadlani, FT Chong, ... Oncogene 37 (10), 1340-1353, 2018 | 35 | 2018 |
| A role of agrin in maintaining the stability of vascular endothelial growth factor receptor-2 during tumor angiogenesis K Njah, S Chakraborty, B Qiu, S Arumugam, A Raju, AV Pobbati, ... Cell reports 28 (4), 949-965. e7, 2019 | 32 | 2019 |
| Two-photon dye cocktail for dual-color 3D imaging of pancreatic beta and alpha cells in live islets BK Agrawalla, HW Lee, WH Phue, A Raju, JJ Kim, HM Kim, NY Kang, ... Journal of the American Chemical Society 139 (9), 3480-3487, 2017 | 29 | 2017 |
| Targeting N-myristoylation for therapy of B-cell lymphomas E Beauchamp, MC Yap, A Iyer, MA Perinpanayagam, JM Gamma, ... Nature Communications 11 (1), 5348, 2020 | 27 | 2020 |
| An intravascular MRI contrast agent based on Gd (DO3A-Lys) for tumor angiography CT Yang, P Chandrasekharan, T He, Z Poh, A Raju, KH Chuang, ... Biomaterials 35 (1), 327-336, 2014 | 18 | 2014 |
| Negative contrast Cerenkov luminescence imaging of blood vessels in a tumor mouse model using [68Ga] gallium chloride JD Steinberg, A Raju, P Chandrasekharan, CT Yang, K Khoo, ... EJNMMI research 4 (1), 1-11, 2014 | 16 | 2014 |
| GREB1: An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer EM Shin, VT Huynh, SA Neja, CY Liu, A Raju, K Tan, NS Tan, ... Science Advances 7 (12), eabe2470, 2021 | 12 | 2021 |
| Super-silencers regulated by chromatin interactions control apoptotic genes Y Zhang, K Chen, Y Cai, A Nambu, YX See, C Fu, A Raju, M Lakshmanan, ... bioRxiv, 2022.01. 17.476559, 2022 | 2 | 2022 |
| p53-NEIL1 co-abnormalities induce genomic instability and promote synthetic lethality with Chk1 inhibition in multiple myeloma having concomitant 17p13 (del) and 1q21 (gain) PJ Teoh, O An, TH Chung, T Vaiyapuri, A Raju, MM Hoppe, SHM Toh, ... Oncogene 41 (14), 2106-2121, 2022 | 1 | 2022 |
| Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis J Zhang, Z Hu, HH Chung, Y Tian, KW Lau, Z Ser, YT Lim, RM Sobota, ... Nature Communications 14 (1), 2439, 2023 | | 2023 |
| Targeting N-myristoylation in B-cell lymphomas as a therapeutic strategy E Beauchamp, MC Yap, MA Perinpanayagam, JM Gamma, KM Vincent, ... Cancer Research 80 (16_Supplement), 5156-5156, 2020 | | 2020 |
| Targeting N-myristoylation in B cell lymphomas as a therapeutic strategy JR Mackey, E Beauchamp, MC Yap, A Iyer, MA Perinpanayagam, ... Cancer Research 79 (13_Supplement), 3046-3046, 2019 | | 2019 |
| GNA13 is a theranostic target that drives drug resistance and cancer stem-like phenotypes in solid tumors SAK Rasheed, HS Leong, M Lakshmanan, A Raju, D Dadlani, FT Chong, ... Cancer Research 77 (13_Supplement), 3887-3887, 2017 | | 2017 |
Si-Shen FENG （冯思慎）Professor of Chemical and Biomolecular Engineering, National University of SingaporeVerified email at nus.edu.sg
